Ranbaxy on a roll with generic Lipitor in Europe and Australia
This article was originally published in Scrip
Executive Summary
Ranbaxy Laboratories continues to roll out its generic version of Pfizer's cholesterol lowering drug Lipitor (atorvastatin) in international markets, the latest being Germany, Italy, Sweden and the Netherlands. Ranbaxy, part of Daiichi Sankyo, last month also launched generic atorvastatin in Australia with three months' exclusivity, and has reported gains in market share in the US.